P

Inventor

STOGNIEW MARTIN

US49 patents
⚠️ This page may combine multiple inventors who share the name “STOGNIEW MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MEDIMMUNE ONCOLOGY INC

14 patents
US6489312B1Dec 3, 2002

Pharmaceutical formulations comprising aminoalkyl phosphorothioates

MEDIMMUNE ONCOLOGY INC49 citations95
US6258821B1Jul 10, 2001

Compositions comprising trimetrexate and methods of their synthesis and use

MEDIMMUNE ONCOLOGY INC43 citations95
US6573253B2Jun 3, 2003

Methods for the administration of amifostine and related compounds

MEDIMMUNE ONCOLOGY INC20 citations92
US6218377B1Apr 17, 2001

Methods for the administration of amifostine and related compounds

MEDIMMUNE ONCOLOGY INC22 citations92
US6407278B2Jun 18, 2002

Stable amorphous amifostine compositions and methods for the preparation and use of the same

MEDIMMUNE ONCOLOGY INC22 citations91
US6384259B1May 7, 2002

Stable amorphous amifostine compositions and dosage form

MEDIMMUNE ONCOLOGY INC25 citations91
US6586476B1Jul 1, 2003

Methods for the treatment of nephro-disorders using aminothiol compounds

MEDIMMUNE ONCOLOGY INC13 citations90
US6239119B1May 29, 2001

Topical administration of amifostine and related compounds

MEDIMMUNE ONCOLOGY INC35 citations90
US6127351AOct 3, 2000

Method for the administration of amifostine and related compounds

MEDIMMUNE ONCOLOGY INC15 citations82
US6841545B2Jan 11, 2005

Stable amorphous amifostine compositions and methods for the preparation of same

MEDIMMUNE ONCOLOGY INC6 citations72
US6753323B2Jun 22, 2004

Topical administration of amifostine and related compounds

MEDIMMUNE ONCOLOGY INC6 citations71
US6258952B1Jul 10, 2001

Thermally stable trimetrexates and processes for producing the same

MEDIMMUNE ONCOLOGY INC6 citations70
US6576635B2Jun 10, 2003

Compositions comprising trimetrexate

MEDIMMUNE ONCOLOGY INC1 citations61
US7105575B2Sep 12, 2006

Methods for the treatment of neuro- disorders using aminothiol compounds

MEDIMMUNE ONCOLOGY INC1 citations60

ONCOCEUTICS INC

13 patents
US9688679B2Jun 27, 2017

7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy

ONCOCEUTICS INC7 citations83
US9376437B2Jun 28, 2016

7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy

ONCOCEUTICS INC11 citations83
US9265765B2Feb 23, 2016

7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy

ONCOCEUTICS INC10 citations83
US10172862B2Jan 8, 2019

Imipridones for gliomas

ONCOCEUTICS INC5 citations82
US10456402B2Oct 29, 2019

7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy

ONCOCEUTICS INC1 citations72
US10266533B2Apr 23, 2019

7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy

ONCOCEUTICS INC1 citations72
US10369154B2Aug 6, 2019

Imipridones for gliomas

ONCOCEUTICS INC1 citations71
US10953014B2Mar 23, 2021

7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy

ONCOCEUTICS INC0 citations62
US9845324B2Dec 19, 2017

7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy

ONCOCEUTICS INC1 citations61
US12102639B2Oct 1, 2024

Imipridones for gliomas

ONCOCEUTICS INC0 citations60
US11116771B2Sep 14, 2021

G protein-coupled receptor (GPCR) modulation by imipridones

ONCOCEUTICS INC0 citations60
US10946022B2Mar 16, 2021

Imipridones for gliomas

ONCOCEUTICS INC0 citations60
US10045992B2Aug 14, 2018

7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy

ONCOCEUTICS INC0 citations51

TRANSCEND THERAPEUTICS INC

7 patents

VICURON PHARM INC

5 patents

US BIOSCIENCE

3 patents

NPI LLC

2 patents

STOGNIEW MARTIN

1 patent

MEDLMMUNE ONCOLOGY INC

1 patent

CHIMERIX INC

1 patent

ALONSO ROBERT

1 patent

MEDIMMUNE LLC

1 patent